Holen Sie sich die Stockscreener-App
0.1328
9.35%
-0.0137
Handel nachbörslich:
.13
-0.0028
-2.11%
Schlusskurs vom Vortag:
$0.1465
Offen:
$0.1451
24-Stunden-Volumen:
3.93M
Relative Volume:
0.78
Marktkapitalisierung:
$2.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.35M
KGV:
-0.2887
EPS:
-0.46
Netto-Cashflow:
$-5.48M
1W Leistung:
-27.59%
1M Leistung:
-36.18%
6M Leistung:
-80.60%
1J Leistung:
-69.77%
1-Tages-Spanne:
$0.1247
$0.1451
1-Wochen-Bereich:
$0.1247
$0.2477
52-Wochen-Spanne:
$0.1247
$3.30
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Firmenname
Shuttle Pharmaceuticals Holdings Inc
Sektor
Telefon
(240) 403-4212
Adresse
401 PROFESSIONAL DRIVE, GAITHERSBURG
Vergleichen Sie SHPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
0.1328 | 2.01M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
164.33 | 75.76B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.87 | 49.79B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.20 | 46.73B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.99 | 20.38B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
283.35 | 14.70B | 2.99B | 1.21B | 1.13B | 25.06 |
Shuttle Pharmaceuticals Holdings Inc Aktie (SHPH) Neueste Nachrichten
Shuttle Pharmaceuticals says reverse stock split to become effective June 16 - Yahoo Finance
# Shuttle Pharmaceuticals plans 25-for-1 reverse stock split By Investing.com - Investing.com South Africa
Shuttle Pharma Announces Reverse Stock Split Will Become Effective On June 16 - marketscreener.com
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time - GlobeNewswire
Shuttle Pharma Announces Major 25:1 Reverse Split: Key Details Every Investor Must Know Before June 16 - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. Proposes 25-for-1 Reverse Stock Split to Comply with Nasdaq Requirements - Nasdaq
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative - GlobeNewswire
Shuttle Pharma Board Approves Major 25:1 Reverse Split to Maintain Nasdaq Listing - Stock Titan
Pre-market Movers: SHPH, WORX, IOVA, PLRZ... - RTTNews
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors - GlobeNewswire
Shuttle Pharma appoints new Chairman to its Board By Investing.com - Investing.com South Africa
Shuttle Pharma appoints new Chairman to its Board - Investing.com Australia
Shuttle Pharma Appoints George Scorsis Chairman Of The Board Of Directors - marketscreener.com
Cancer Treatment Pioneer Shuttle Pharma Taps 25-Year Industry Leader George Scorsis to Drive Growth Strategy - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Increase in Short Interest - Defense World
Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Johnson Matthey (LON:JMAT) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Invesco WilderHill Clean Energy ETF (NYSEARCA:PBW) Shares Sold by Bank of America Corp DE - Defense World
Shuttle Pharmaceuticals slashes exec salaries by 70% as it fights to preserve cash - The Business Journals
Shuttle Pharmaceuticals Holdings Implements 70% Salary Reduction For ExecutivesSEC Filing - marketscreener.com
Shuttle Pharmaceuticals Announces Major Salary Reductions - TipRanks
SHPH stock plunges to 52-week low of $0.2 amid market challenges - Investing.com India
Shuttle Pharma Provides Corporate Update - citybiz
Shuttle Pharmaceuticals Announces Leadership Changes and Meeting Outcomes - TipRanks
Shuttle Pharma Phase 2 Brain Cancer Trial Shows Promise: 84% Patient Completion Rate Signals Strong Progress - Stock Titan
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Certain Common Stock of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2025. - marketscreener.com
Certain Pre-Funded Warrants of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 12-MAY-2025. - marketscreener.com
Shuttle Pharma’s glioblastoma trial reaches halfway mark By Investing.com - Investing.com Nigeria
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharma’s glioblastoma trial reaches halfway mark - Investing.com
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial - GlobeNewswire
Shuttle Pharmaceuticals Holdings Offers Up To 10,000,000 Shares Of Common Stock - marketscreener.com
Did Shuttle Pharmaceuticals Holdings Inc (SHPH) perform well in the last session? - uspostnews.com
Market Resilience: Shuttle Pharmaceuticals Holdings Inc (SHPH) Finishes Weak at 0.27, Down -8.74 - DWinneX
Renaissance Technologies LLC Purchases 26,808 Shares of CPI Card Group Inc. (NASDAQ:PMTS) - Defense World
Nothing is Better Than Shuttle Pharmaceuticals Holdings Inc (SHPH) stock at the moment - Sete News
Shuttle Pharmaceuticals Holdings Inc [SHPH] moved up 0.12: Why It’s Important - dbtnews.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Small Cap Stock Shuttle Pharmaceuticals Holdings Inc (SHPH) Is A Buy – Analysts - Marketing Sentinel
The Psychology of Shuttle Pharmaceuticals Holdings Inc Inc. (SHPH) Price Performance: Understanding Market Sentiment - investchronicle.com
A review of SHPH’s current quarter earnings predictions - uspostnews.com
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - GlobeNewswire
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World
SHPH stock plunges to 52-week low of $0.33 amid steep annual decline - Investing.com India
Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer - marketscreener.com
Shuttle Pharma files patent for cancer treatment innovation - Investing.com Australia
Finanzdaten der Shuttle Pharmaceuticals Holdings Inc-Aktie (SHPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):